Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Cytomegalovirus Infection

Free Subscription Articles published in Bone Marrow Transplant Retrieve available abstracts of 16 articles: HTML format

Single Articles

November 2021
1. GARNICA M, Dalcolmo S, Gaio B, de Almeida AR, et al
   Pre-engraftment Cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation and its impact on engraftment.
   Bone Marrow Transplant. 2021 Nov 1. pii: 10.1038/s41409-021-01520.
   PubMed    
   
   
   October 2021
2. WANG X, Yu U, Yang C, Wang C, et al
   Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation.
   Bone Marrow Transplant. 2021 Oct 20. pii: 10.1038/s41409-021-01499.
   PubMed    
   
   
   July 2021
3. KANG HM, Kim SK, Ryu IH, Lee JW, et al
   Clinical characteristics and viral load patterns in children with cytomegalovirus gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
   Bone Marrow Transplant. 2021 Jul 17. pii: 10.1038/s41409-021-01394.
   PubMed     Abstract available
   
   
   May 2021
4. KUZICH JA, Kankanige Y, Guinto J, Ryland G, et al
   T cell receptor beta locus sequencing early post-allogeneic stem cell transplant identifies patients at risk of initial and recurrent cytomegalovirus infection.
   Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01354.
   PubMed     Abstract available
   
   
   
5. STYCZYNSKI J, Tridello G, Xhaard A, Medinger M, et al
   Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study.
   Bone Marrow Transplant. 2021;56:1171-1179.
   PubMed     Abstract available
   
   
   January 2021
6. YOKOYAMA H, Kanda J, Kawahara Y, Uchida N, et al
   Reduced leukemia relapse through cytomegalovirus reactivation in killer cell immunoglobulin-like receptor-ligand-mismatched cord blood transplantation.
   Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01203.
   PubMed     Abstract available
   
   
   December 2020
7. BEAUVAIS D, Drumez E, Blaise D, Peffault de Latour R, et al
   Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study.
   Bone Marrow Transplant. 2020 Dec 18. pii: 10.1038/s41409-020-01178.
   PubMed     Abstract available
   
   
   
8. SOLANO C, Vazquez L, Gimenez E, de la Camara R, et al
   Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment.
   Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01157.
   PubMed     Abstract available
   
   
   
9. MORI T, Kikuchi T, Koh M, Koda Y, et al
   Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening.
   Bone Marrow Transplant. 2020 Dec 12. pii: 10.1038/s41409-020-01176.
   PubMed     Abstract available
   
   
   November 2020
10. MORI Y, Jinnouchi F, Takenaka K, Aoki T, et al
    Efficacy of prophylactic letermovir for cytomegalovirus reactivation in hematopoietic cell transplantation: a multicenter real-world data.
    Bone Marrow Transplant. 2020 Nov 2. pii: 10.1038/s41409-020-01082.
    PubMed     Abstract available
    
    
    August 2020
11. KANG SH, Yoo JW, Seo JK, Kim H, et al
    The role of interim-foscarnet prophylaxis in preventing cytomegalovirus infection after ex vivo alphabeta T cell-depleted haploidentical hematopoietic cell transplant in children.
    Bone Marrow Transplant. 2020 Aug 8. pii: 10.1038/s41409-020-01020.
    PubMed    
    
    
    May 2020
12. HUNTLEY D, Gimenez E, Pascual MJ, Vazquez L, et al
    Peripheral blood regulatory T cells and occurrence of Cytomegalovirus DNAemia after unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide.
    Bone Marrow Transplant. 2020 May 23. pii: 10.1038/s41409-020-0950.
    PubMed    
    
    
    April 2020
13. CARAPITO R, Aouadi I, Pichot A, Spinnhirny P, et al
    Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status.
    Bone Marrow Transplant. 2020 Apr 14. pii: 10.1038/s41409-020-0886.
    PubMed     Abstract available
    
    
    March 2020
14. HUNTLEY D, Gimenez E, Pascual MJ, Remigia MJ, et al
    Reconstitution of cytomegalovirus-specific T-cell immunity following unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide.
    Bone Marrow Transplant. 2020 Mar 23. pii: 10.1038/s41409-020-0865.
    PubMed     Abstract available
    
    
    January 2020
15. YAN CH, Wang Y, Mo XD, Sun YQ, et al
    Incidence, risk factors, and outcomes of cytomegalovirus retinitis after haploidentical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Jan 28. pii: 10.1038/s41409-020-0790.
    PubMed     Abstract available
    
    
    October 2019
16. SHARMA P, Gakhar N, MacDonald J, Abidi MZ, et al
    Letermovir prophylaxis through day 100 post transplant is safe and effective compared with alternative CMV prophylaxis strategies following adult cord blood and haploidentical cord blood transplantation.
    Bone Marrow Transplant. 2019 Oct 29. pii: 10.1038/s41409-019-0730.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: